MPM BioImpact LLC - INHIBRX INC ownership

INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 111 filers reported holding INHIBRX INC in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
MPM BioImpact LLC ownership history of INHIBRX INC
ValueSharesWeighting
Q1 2023$22,498,342
-29.0%
1,192,281
-7.3%
5.84%
-28.9%
Q4 2022$31,697,758
+38.0%
1,286,435
+0.5%
8.22%
+51.1%
Q3 2022$22,976,000
+97.8%
1,279,995
+25.1%
5.44%
+68.7%
Q2 2022$11,615,0001,023,3253.23%
Other shareholders
INHIBRX INC shareholders Q3 2023
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 542,586$18,074,0003.33%
Meridian Wealth Advisors, LLC 122,315$4,074,0001.14%
SPHERA FUNDS MANAGEMENT LTD. 310,077$10,329,0000.87%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 1,028,303$34,253,0000.86%
Ikarian Capital, LLC 289,850$9,654,0000.68%
Perceptive Advisors 1,121,490$37,357,0000.54%
Soleus Capital Management, L.P. 97,979$3,264,0000.51%
VIKING GLOBAL INVESTORS LP 5,305,866$176,738,0000.48%
Alaethes Wealth LLC 19,341$644,0000.47%
ArrowMark Colorado Holdings LLC 1,385,642$46,156,0000.36%
View complete list of INHIBRX INC shareholders